title: Impact of Amikacin on Pseudothrombocytopenia.
authors.affiliation: Haematology and Coagulation Laboratory, Mount Sinai Hospital, Toronto, ON, Canada.
authors.forename: Payman Baradar
authors.initials: PB
authors.lastname: Bokaei
authors.forename: Daniel
authors.initials: D
authors.lastname: Grabovsky
authors.forename: Nadine
authors.initials: N
authors.lastname: Shehata
authors.forename: Chen
authors.initials: C
authors.lastname: Wang
mesh_terms: D000583:Amikacin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002951:Citrates / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D005189:False Positive Reactions; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D010976:Platelet Count / Q000592:standards; D061251:Primary Cell Culture; D000077559:Sodium Citrate; D013921:Thrombocytopenia / Q000097:blood / Q000175:diagnosis*
chemical_list: D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D002951:Citrates; D010975:Platelet Aggregation Inhibitors; D000077559:Sodium Citrate; D000583:Amikacin; D006493:Heparin; D004492:Edetic Acid